Diabetes Care, Vol 21, Issue 4 539-545, Copyright © 1998 by American Diabetes Association

ARTICLES

Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study

AM Adlerberth, A Rosengren and L Wilhelmsen
Section of Diabetes, Sahlgrenska University Hospital at Ostra, Goteborg, Sweden.

OBJECTIVE: To assess the relation between cardiovascular risk factors and long-term cause-specific mortality risk in middle-aged diabetic men, compared with men without diabetes. RESEARCH DESIGN AND METHODS: This prospective study analyzes a large random population sample of men over a follow-up of 16 years. At baseline in 1974-1977, 249 men with diabetes and 6,851 men without diabetes, all aged 51-59 years, were identified. There were 2,126 deaths, 724 of which were due to coronary heart disease (CHD) and 1,001 deaths were due to any cardiovascular disease (CVD) cause. RESULTS: After adjustment for age, serum cholesterol, systolic blood pressure, smoking, BMI, and coronary disease at baseline, the relative risk of dying from any cause was 2.50 (95% CI, 2.11-2.95) in men with diabetes, compared with nondiabetic men, and 2.87 (2.31-3.57) for cardiovascular death. Men with diabetes had no significant excessive risk of dying from cancer or violent causes, but the relative risk of dying from any other noncardiovascular cause was 3.69 (2.55-5.34). Most of these deaths were due to diabetes and its complications. Hypercholesterolemia, smoking, and elevated systolic blood pressure predicted both coronary and all-cause mortality in diabetic as well as in nondiabetic men. Men with diabetes and serum cholesterol > 7.2 mmol/l had a risk of dying from coronary disease of 45.3 and from any cause of 76.1 per 1,000 observation-years. In men with diabetes, the relative risk of dying associated with serum cholesterol > 7.2 mmol/l, as compared with < 5.2 mmol/l, was 1.78 (95% CI, 1.05-3.02). The corresponding risk for nondiabetic men was 1.23 (1.04-1.46), and there was a statistically significant interaction between serum cholesterol and diabetes (P = 0.004). CONCLUSIONS: In men with diabetes, hypercholesterolemia, smoking, and hypertension predict coronary mortality risk, as well as mortality risk from all causes. Men with both diabetes and hypercholesterolemia have severely compromised survival and should be targeted for intervention aimed at lowering their lipid levels.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. R. Dagenais MD, A. St-Pierre PhD, P. Gilbert MD, B. Lamarche PhD, J.-P. Despres PhD, P.-M. Bernard MSc, and P. Bogaty MD Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease Can. Med. Assoc. J., January 6, 2009; 180(1): 40 - 47. [Abstract] [Full Text] [PDF]

				S. S Lund, L. Tarnow, C. D A Stehouwer, C. G Schalkwijk, T. Teerlink, J. Gram, K. Winther, M. Frandsen, U. M Smidt, O. Pedersen, et al. Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes Eur. J. Endocrinol., May 1, 2008; 158(5): 631 - 641. [Abstract] [Full Text] [PDF]

				S. M. Grundy Diabetes and Coronary Risk Equivalency: What does it mean? Diabetes Care, February 1, 2006; 29(2): 457 - 460. [Full Text] [PDF]

				Prepared by: British Cardiac Society, British Hype JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart, December 1, 2005; 91(suppl_5): v1 - v52. [Full Text] [PDF]

				E. J. Boyko Progress in the Estimation of Mortality due to Diabetes Diabetes Care, September 1, 2005; 28(9): 2320 - 2321. [Full Text] [PDF]

				A. R. Folsom, L. E Chambless, B. B. Duncan, A. C. Gilbert, J. S. Pankow, and the Atherosclerosis Risk in Communities Study Inve Prediction of Coronary Heart Disease in Middle-Aged Adults With Diabetes Diabetes Care, October 1, 2003; 26(10): 2777 - 2784. [Abstract] [Full Text] [PDF]

				R.M. Conroy, K. Pyorala, A.P. Fitzgerald, S. Sans, A. Menotti, G. De Backer, D. De Bacquer, P. Ducimetiere, P. Jousilahti, U. Keil, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur. Heart J., June 1, 2003; 24(11): 987 - 1003. [Abstract] [Full Text] [PDF]

				G. Verlato, G. Zoppini, E. Bonora, and M. Muggeo Mortality From Site-Specific Malignancies in Type 2 Diabetic Patients From Verona Diabetes Care, April 1, 2003; 26(4): 1047 - 1051. [Abstract] [Full Text] [PDF]

				Asia Pacific Cohort Studies Collaboration The Effects of Diabetes on the Risks of Major Cardiovascular Diseases and Death in the Asia-Pacific Region Diabetes Care, February 1, 2003; 26(2): 360 - 366. [Abstract] [Full Text] [PDF]

				L. Poulsen Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 222 - 242. [Abstract] [PDF]

				A. M. Kanaya, D. Grady, and E. Barrett-Connor Explaining the Sex Difference in Coronary Heart Disease Mortality Among Patients With Type 2 Diabetes Mellitus: A Meta-analysis Arch Intern Med, August 12, 2002; 162(15): 1737 - 1745. [Abstract] [Full Text] [PDF]

				E.S. Kilpatrick, B.G. Keevil, C. Jagger, R.J. Spooner, and M. Small Determinants of raised C-reactive protein concentration in type 1 diabetes QJM, April 1, 2000; 93(4): 231 - 236. [Abstract] [Full Text] [PDF]

				Other Articles Noted Evid. Based Nurs., October 1, 1998; 1(4): 100 - 104. [Full Text]